Analyst Consensus ?
ConsensusHold29 ratings
Bullish1448.3%
Neutral1448.3%
Bearish13.4%
FN2 Earnings Intelligence
Tyson Foods, Inc. (TSN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jul 2, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jun 18, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Mizuho | Outperform | Buy | Maintain | Mar 26, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 3, 2026 |
| Barclays | Overweight | Overweight | Maintain | Feb 3, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| HSBC | Reduce | Reduce | Maintain | May 7, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 7, 2023 |
| Argus Research | Hold | Buy | Downgrade | Sep 13, 2022 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 13, 2019 |
| Argus | Buy | Hold | Upgrade | May 14, 2019 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Vertical Group | Buy | Hold | Upgrade | Jan 10, 2019 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 8, 2018 |
| Pivotal Research | Hold | Sell | Upgrade | Nov 13, 2017 |
| Jefferies | Buy | Buy | Maintain | Oct 30, 2017 |
| CLSA | Buy | Outperform | Maintain | Oct 10, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 4, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jan 5, 2016 |
| Cleveland Research | Buy | Neutral | Upgrade | Feb 5, 2015 |
| KeyBanc | Buy | Buy | Maintain | Jul 29, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jul 10, 2013 |
| Miller Tabak | Buy | Neutral | Upgrade | May 7, 2013 |
Upside is calculated against the persisted current price $60.65. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Coker Palmer | Thomas Palmer | $65 | $57.48 | +7.2% | Jul 14, 2026 |
| Bernstein | Analyst unavailable | $63 | $58.43 | +3.9% | Jul 2, 2026 |
| Piper Sandler | Michael Lavery | $78 | $56.2 | +28.6% | Jun 18, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $68.76 | +31.9% | May 4, 2026 |
| Bernstein | Analyst unavailable | $69 | $65.74 | +13.8% | Feb 3, 2026 |
| BMO Capital | Andrew Strelzik | $73 | $65.74 | +20.4% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $78 | $65.74 | +28.6% | Feb 3, 2026 |
| BMO Capital | Analyst unavailable | $67 | $56.2 | +10.5% | Jan 8, 2026 |
| Piper Sandler | Michael Lavery | $61 | $59.56 | +0.6% | Dec 12, 2025 |
| Stephens | Pooran Sharma | $61 | $55.75 | +0.6% | May 6, 2025 |
| Coker Palmer | Thomas Palmer | $60 | $60.54 | -1.1% | Apr 15, 2025 |
| Piper Sandler | Michael Lavery | $58 | $61.69 | -4.4% | Nov 13, 2024 |
| BMO Capital | Andrew Strelzik | $62 | $61.69 | +2.2% | Nov 13, 2024 |
| Barclays | Benjamin Theuer | $76 | $62.66 | +25.3% | Nov 12, 2024 |
| Bank of America Securities | Peter Galbo | $62 | $59.85 | +2.2% | Oct 15, 2024 |
| Piper Sandler | Michael Lavery | $50 | $60.52 | -17.6% | Sep 25, 2024 |
| Barclays | Benjamin Theuer | $72 | $65.13 | +18.7% | Sep 5, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $62.08 | -1.1% | Aug 6, 2024 |
| Coker Palmer | Thomas Palmer | $63 | $62.51 | +3.9% | Aug 5, 2024 |
| Piper Sandler | Michael Lavery | $57 | $58.33 | -6.0% | May 7, 2024 |
| BMO Capital | Andrew Strelzik | $58 | $58.28 | -4.4% | May 7, 2024 |
| Barclays | Benjamin Theuer | $69 | $58.12 | +13.8% | Apr 16, 2024 |
| Coker Palmer | Thomas Palmer | $62 | $57.6 | +2.2% | Apr 3, 2024 |
| Loop Capital Markets | Andrew Strelzik | $46 | $47.77 | -24.2% | Nov 14, 2023 |
| Stephens | Ben Bienvenu | $70 | $47.58 | +15.4% | Nov 14, 2023 |
| Barclays | Benjamin Theurer | $50 | $46.39 | -17.6% | Nov 10, 2023 |
| UBS | Kevin Caliendo | $37 | $52.66 | -39.0% | Jul 24, 2023 |
| Deutsche Bank | Steve Powers | $35 | $50.39 | -42.3% | May 19, 2023 |
| Bernstein | Alexia Howard | $48 | $48.95 | -20.9% | May 9, 2023 |
| J.P. Morgan | Analyst unavailable | $63 | $59.92 | +3.9% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $58 | $61.08 | -4.4% | Feb 7, 2023 |
| Goldman Sachs | Analyst unavailable | $66 | $61.08 | +8.8% | Feb 7, 2023 |
| Piper Sandler | Analyst unavailable | $65 | $65.75 | +7.2% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $58 | $67.33 | -4.4% | Nov 28, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $64.34 | +15.4% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $75 | $64.83 | +23.7% | Nov 15, 2022 |
| Piper Sandler | Michael Lavery | $79 | $79.92 | +30.3% | Aug 9, 2022 |
| Piper Sandler | Michael Lavery | $85 | $92.84 | +40.1% | May 10, 2022 |
| Piper Sandler | Michael Lavery | $81 | $90.1 | +33.6% | May 3, 2022 |
| BMO Capital | Kenneth Zaslow | $99 | $87.14 | +63.2% | Mar 18, 2022 |
Track every rating change on TSN the moment it posts. Free to start.
Start free